Toshihiro Oguma
About
Toshihiro Oguma is a scholar working on Molecular Biology, Physiology and Oncology.
According to data from OpenAlex, Toshihiro Oguma has authored 34 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Physiology and 7 papers in Oncology. Recurrent topics in Toshihiro Oguma's work include Cancer therapeutics and mechanisms (9 papers), Glycosylation and Glycoproteins Research (8 papers) and Lysosomal Storage Disorders Research (8 papers). Toshihiro Oguma is often cited by papers focused on Cancer therapeutics and mechanisms (9 papers), Glycosylation and Glycoproteins Research (8 papers) and Lysosomal Storage Disorders Research (8 papers). Toshihiro Oguma collaborates with scholars based in Japan, United States and Colombia. Toshihiro Oguma's co-authors include Shunji Tomatsu, Adriana M. Montaño, Hiroshi Masumoto, Masazumi Kojima, Masaya Tachibana, Satoshi Kunitada, Jeanne Mendell‐Harary, Osamu Okazaki, H. Oikawa and Vũ Chí Dũng and has published in prestigious journals such as Journal of Clinical Oncology, Analytical Biochemistry and Human Molecular Genetics.
In The Last Decade
Toshihiro Oguma
34 papers receiving 1.7k citations
Peers
Toshihiro Oguma
Stefano Manarini Italy
Órla P. Barry Ireland
Luca Puccetti Italy
G. Defreyn Belgium
J.A. Gevers Leuven Netherlands
Hiromu Nakajima Japan
Zhongren Ding China
Tessa J. Barrett United States
Lucia Stefanini Italy
Michelle Wilson United Kingdom
Citations per year, relative to Toshihiro Oguma Toshihiro Oguma (= 1×)
peers
Stefano Manarini
Countries citing papers authored by Toshihiro Oguma
Since
Specialization
Citations
This map shows the geographic impact of Toshihiro Oguma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshihiro Oguma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshihiro Oguma more than expected).
Fields of papers citing papers by Toshihiro Oguma
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Toshihiro Oguma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshihiro Oguma. The network helps show where Toshihiro Oguma may publish in the future.
Co-authorship network of co-authors of Toshihiro Oguma
This figure shows the co-authorship network connecting the top 25 collaborators of Toshihiro Oguma. A scholar is included among the top collaborators of Toshihiro Oguma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshihiro Oguma. Toshihiro Oguma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Failmezger, Henrik, Jessica Chan, Anatoliy Shumilov, et al.. (2023). Computational pathology–based HER2 quantification to identify novel biomarkers in gastric cancer (GC).. Journal of Clinical Oncology. 41(4_suppl). 449–449.
2.
Lee, Jih‐Hsiang, Tom Wei‐Wu Chen, Chih‐Hung Hsu, et al.. (2019). A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors. Investigational New Drugs. 38(1). 99–110.
3.
Shimizu, Takako, et al.. (2015). Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Novel Factor Xa Inhibitor DY-807f in Healthy Volunteers. Thrombosis Research. 135(4). 594–601.
4.
Tomatsu, Shunji, Adriana M. Montaño, Vũ Chí Dũng, et al.. (2010). Enhancement of Drug Delivery: Enzyme-replacement Therapy for Murine Morquio A Syndrome. Molecular Therapy. 18(6). 1094–1102.
5.
Ohashi, Amiko, et al.. (2009). Sacral dimple: incidental findings from newborn evaluation (Case Presentation). Acta Paediatrica. 98(5). 768–769.
6.
Tomatsu, Shunji, Adriana M. Montaño, Toshihiro Oguma, et al.. (2009). Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry. Molecular Genetics and Metabolism. 99(2). 124–131.
7.
Montaño, Adriana M., H. Oikawa, Shunji Tomatsu, et al.. (2008). Acidic amino acid tag enhances response to enzyme replacement in mucopolysaccharidosis type VII mice. Molecular Genetics and Metabolism. 94(2). 178–189.
8.
Oguma, Toshihiro, Shunji Tomatsu, & Osamu Okazaki. (2007). Analytical method for determination of disaccharides derived from keratan sulfates in human serum and plasma by high‐performance liquid chromatography/turbo‐ionspray ionization tandem mass spectrometry. Biomedical Chromatography. 21(4). 356–362.
9.
Oguma, Toshihiro, Shunji Tomatsu, Adriana M. Montaño, & Osamu Okazaki. (2007). Analytical method for the determination of disaccharides derived from keratan, heparan, and dermatan sulfates in human serum and plasma by high-performance liquid chromatography/turbo ionspray ionization tandem mass spectrometry. Analytical Biochemistry. 368(1). 79–86.
10.
Tomatsu, Shunji, Adriana M. Montaño, Amiko Ohashi, et al.. (2007). Enzyme replacement therapy in a murine model of Morquio A syndrome. Human Molecular Genetics. 17(6). 815–824.
11.
Oguma, Toshihiro, et al.. (2005). Validation study of a method for assaying DE-310, a macromolecular carrier conjugate containing an anti-tumor camptothecin derivative, and the free drug in human plasma by HPLC and LC/MS/MS. Journal of Chromatography B. 818(2). 249–256.
12.
Oguma, Toshihiro, et al.. (2004). Validation study of a method for assaying DE‐310, a macromolecular carrier conjugate containing an anti‐tumor camptothecin derivative, and the free drug in tumor tissue by high performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry. Biomedical Chromatography. 19(1). 19–26.
13.
Schöffski, Patrick, Gernot Beutel, O. Bolte, et al.. (2004). Phase I and pharmacokinetic study of TZT-1027, a novel synthetic dolastatin 10 derivative, administered as a 1-hour intravenous infusion every 3 weeks in patients with advanced refractory cancer. Annals of Oncology. 15(4). 671–679.
14.
Oguma, Toshihiro, et al.. (2004). Validation study of assay method for DE-310, a novel polymer-bound camptothecin derivative, and the free drug in mouse plasma by liquid chromatography with fluorimetric detection. Journal of Chromatography B. 801(2). 157–164.
15.
Oguma, Toshihiro, Hidenao Toyoda, Toshihiko Toida, & Toshio Imanari. (2001). Analytical method of heparan sulfates using high-performance liquid chromatography turbo-ionspray ionization tandem mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 754(1). 153–159.
16.
Oguma, Toshihiro, et al.. (2001). Validation study of assay method for DX‐8951 and its metabolite in human plasma and urine by high‐performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry. Biomedical Chromatography. 15(2). 108–115.
17.
Oguma, Toshihiro, Hidenao Toyoda, Toshihiko Toida, & Toshio Imanari. (2001). Analytical method of chondroitin/dermatan sulfates using high performance liquid chromatography/turbo ionspray ionization mass spectrometry: application to analyses of the tumor tissue sections on glass slides. Biomedical Chromatography. 15(5). 356–362.
18.
Oguma, Toshihiro. (2001). Antitumor drugs possessing topoisomerase I inhibition: applicable separation methods. Journal of Chromatography B Biomedical Sciences and Applications. 764(1-2). 49–58.
19.
Oguma, Toshihiro, et al.. (2000). Sensitive high-performance liquid chromatographic method for the determination of the lactone form and the lactone plus hydroxy-acid forms of the new camptothecin derivative DX-8951 in human plasma using fluorescence detection. Journal of Chromatography B Biomedical Sciences and Applications. 740(2). 237–245.
20.
Eckhardt, S. Gail, Howard A. Burris, John R. Eckardt, et al.. (1996). A phase I clinical and pharmacokinetic study of the angiogenesis inhibitor, tecogalan sodium. Annals of Oncology. 7(5). 491–496.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Stefano Manarini Breakdown of academic impact, for papers by Órla P. Barry Breakdown of academic impact, for papers by Luca Puccetti Breakdown of academic impact, for papers by G. Defreyn Breakdown of academic impact, for papers by J.A. Gevers Leuven Breakdown of academic impact, for papers by Hiromu Nakajima Breakdown of academic impact, for papers by Zhongren Ding Breakdown of academic impact, for papers by Tessa J. Barrett Breakdown of academic impact, for papers by Lucia Stefanini Breakdown of academic impact, for papers by Michelle Wilson